Impact of Different Thymic Pathologies on the Clinical Course of Myasthenia Gravis: A Population Wide Study in Latvia / Aizkrūts Dziedzera Patoloģiju Ietekmeu uz Myasthenia Gravis Klīnisko Gaitu: Populācijas Pētījums Latvijā
By:
References
- Avidan, N., Panse, R., Berrih-Aknin, S., Miller, A. (2014). Genetic basis of myasthenia gravis:Acomprehensive review. J. Autoimmun., 52, 146-153.
- Berrih-Aknin, S., Ruhlmann, N., Bismuth, J., Cizeron-Clairac, G., Zelman, E., Shachar, I., Dartevelle, P., de Rosbo, N. K., Le Panse, R. (2009). CCL21 overexpressed on lymphatic vessels drives thymus hyperplasia in myasthenia. Ann. Neurol., 66 (4), 521-531.
- Berrih-Aknin, S., Panse, R. (2014). Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms. J. Autoimmun., 52, 90-100.
- Budde, J., Morris, C. D., Gal, A. A., Mansour, K. A., Miller, J. I. (2001). Predictors of outcome in thymectomy for myasthenia gravis. Ann. Thor. Surg., 72 (1), 197-202.
- Cavalcante, P., Le Panse, R., Berrih-Aknin, S., Maggi, L., Antozzi, C., Baggi, F., Bernasconi, P., Mantegazza, R. (2011). The thymus in myasthenia gravis: Site of ‘innate autoimmunity’? Muscle & Nerve, 44 (4), 467-484. Engels, E. A. (2010). Epidemiology of thymoma and associated malignancies. J. Thor. Oncol., 5 (10), suppl. 4, s260-265.
- Gronseth, G. S., Barohn, R. J. (2000). Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 55 (1), 7-15.
- Huang, C. H., Hsu, H. S., Huang, B. S., Lee, H. C., Kao, K. P., Hsu, W. H., Huang, M. H. (2005). Factors influencing the outcome of transsternal thymectomy for myasthenia gravis. Acta Neurol. Scand., 112 (2), 108-114.
- Jaretzki, A., Barohn, R. J., Ernstoff, R. M., Kaminski, H. J., Keesey, J. C., Penn, A. S., Sanders, D. B. (2000). Myasthenia gravis: Recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Ann. Thor. Surg., 70 (1), 327-334.
- Kawaguchi, N., Kuwabara, S., Nemoto, Y., Fukutake, T., Arimura, K., Osame, M., Hattori, T. (2007). Effects of thymectomy on late-onset myasthenia gravis without thymoma. Clin. Neurol. Neurosurg., 109 (10), 858-861.
- Luo, Y., Pan, D. J., Chen, F. F., Zhu, M. H., Wang, J., Zhang, M. (2014). Effectiveness of thymectomy in nonthymomatous myasthenia gravis: A systemtic review. J. Huazhong Univ. Sci. Technol., 34 (6), 942-949.
- Lynch, H. E., Goldberg, G. L., Chidgey, A., Van den Brink, M., Boyd, R., Sempowski, G. D. (2009). Thymic involution and immune reconstitution. Trends Immunol., 30 (7), 366-373.
- Marx, A., Muller-Hermelink, H., Strobel, P. (2003). The role of thymomas in the development of myasthenia gravis. Ann. NY Acad. Sci., 998, 223-236.
- Marx, A., Willcox, N., Leite, M. I., Chuang, W. Y., Schalke, B., Nix, W., Ströbel, P. (2010). Thymoma and paraneoplastic myasthenia gravis. Autoimmunity, 44 (5-6), 413-27.
- Meriggioli, M. N., Sanders, D. B. (2009). Autoimmune myasthenia gravis: Emerging clinical and biological heterogeneity. Lancet Neurol., 8 (5), 475-490.
- Muller-Hermelink, H., Marx, A. (1999). Pathological aspects of malignant and benign thymic disorders. Ann. NY Acad. Sci., 2, 5-14.
- Steinmann, G. G., Klaus, B., Müller-Hermelink, H. K. (1985). The involution of the ageing human thymic epithelium is independent of puberty. Scand. J. Immunol., 22 (5), 563-575.
Language: English
Page range: 210 - 214
Submitted on: May 12, 2015
Published on: Apr 12, 2016
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Keywords:
Related subjects:
© 2016 Anete Zieda, Kristīne Rāviņa, Lelde Pelčere, Maruta S. Naudiņa, Inese Kamša, Nataļja Kurjāne, Viktorija Ķēniņa, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.